SCHEMBL1800967

SCHEMBL1800967

COC(=O)c1cc(Cl)ccc1NC(=O)C(=O)NC(c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
KDM4E B2RXH2 2/20 0.44
HSD17B10 Q99714 1/20 0.44
ALDH1A1 P00352 4/20 0.44
NPSR1 Q6W5P4 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
GAA P10253 2/20 0.43
LMNA P02545 2/20 0.43
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
RECQL P46063 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CNR1 P21554 1/20 0.42
ABL1 P00519 1/20 0.42
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1799759 0.87 KDM4E (0.55) KDM4EHSD17B10MEN1KMT2AGAA
SCHEMBL1798978 0.83 SERPINE1 (0.53) KDM4EHSD17B10ALDH1A1L3MBTL1MEN1
SCHEMBL1798282 0.81 ALDH1A1 (0.60) KDM4EALDH1A1NPSR1L3MBTL1MEN1
SCHEMBL420909 0.79 NPSR1 (0.56) KDM4EALDH1A1NPSR1MEN1KMT2A
SCHEMBL4737582 0.79 ALDH1A1 (0.50) CRHBPCRHR2KDM4EHSD17B10ALDH1A1
SCHEMBL418724 0.76 ALDH1A1 (0.52) KDM4EHSD17B10ALDH1A1NPSR1L3MBTL1
SCHEMBL3784326 0.74 KDM4E (0.62) KDM4EHSD17B10ALDH1A1NPSR1MEN1
SCHEMBL5928677 0.74 KDM4E (0.71) KDM4EHSD17B10ALDH1A1NPSR1MEN1
SCHEMBL3708748 0.73 KDM4E (0.58) KDM4EHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL1794963 0.73 SERPINE1 (0.52) KDM4EHSD17B10ALDH1A1NPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 CRHBP 1216/4885CRHR2 3177/4885KDM4E 4309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.